Nasdaq Markets

Investors in 2020 have witnessed two wild extremes crammed into about a six-month time frame. During the first quarter, panic and uncertainty surrounding the coronavirus disease 2019 (COVID-19) pandemic sent the broad-based S&P 500 screaming to its fastest and steepest bear-

If you think industrial assembly lines in the U.S. aren't running yet as the COVID-19 pandemic continues to rage, think again. The closely watched manufacturing index from the Institute for Supply Management (ISM) hit a 21-month high of 56% in August, reflecting a strong uptick

Nobody wants to think about stocks crashing in 2020 the way they did back in March, but the reality is that we just don't know what the pandemic has in store. If cases skyrocket, or there's bad news on the vaccine front, stocks could react negatively.

You may not realize it, but there's a very good chance you'll rely on Social Security income to some degree when you retire.

Moderna (NASDAQ: MRNA) has been one of the superstars of the coronavirus vaccine race -- from a share performance and vaccine development perspective. The biotech company's shares have soared as it went from first to start human trials to a phase 3 trial in about four months.

Image source: Getty Images

Image source: Getty Images

EPR Properties (NYSE: EPR) specializes in real estate holdings that are experiential in nature, a unique approach among real estate investment trusts (REITs). In the face of the fast-spreading coronavirus, such assets quickly became pariahs. While the situation was terrible at t

It's been nothing short of a crazy year for Wall Street and investors. The panic and uncertainty caused by the unprecedented coronavirus disease 2019 (COVID-19) pandemic initially sent the broad-based S&P 500 (SNPINDEX: ^GSPC) lower by 34% in just under five weeks. The 17 ca

Artificial intelligence (AI) is a hot topic these days. Many companies rely on machine learning and deep data analysis to take their business operations to the next level. Other companies want to supply the needed tools to make a reality out of those AI-powered dreams. The COVID

The Pentagon on Friday reaffirmed its decision to give Microsoft (NASDAQ: MSFT) a massive $10 billion cloud computing contract, but runner-up Amazon (NASDAQ: AMZN) has vowed to press on against what it called a "politically corrupted contract award."

With the U.S. presidential election scheduled around the same time that the first coronavirus vaccines will be up for potential authorization or approval by the Food and Drug Administration (FDA), there's been a lot of speculation that the current administration might pressure t

The recent surge higher in Tesla (NASDAQ: TSLA) shares was attributed, in part, to anticipation that the electric-vehicle maker would soon be added to the S&P 500 Index. But the new list is out, and Tesla isn't on it. This caused Tesla shares to fall 7% in Friday's after-hou

Warren Buffett-led Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) continues to scale back on banking exposure. Regulatory paperwork filed late Friday indicates the investment company now owns a little more than 136 million shares of Wells Fargo (NYSE: WFC), down 101 million shar

Image source: The Motley Fool.

In this episode of Motley Fool Money, Chris Hill chats with Motley Fool analysts Jason Moser and Andy Cross about the latest headlines and quarterly reports. They have news on a surprising potential acquisition, impressive results in the CRM and SaaS space, some stocks hitting a

In this episode of MarketFoolery, Chris Hill chats with Motley Fool analyst Bill Barker about the latest headlines and market reports from Wall Street. They discuss Zoom Video Communications' (NASDAQ: ZM) quarterly report. They've got news on a new membership service in the e-c

What happened Technology stocks' September swoon continued on Friday. By the close of trading, shares of Amazon (NASDAQ: AMZN), Facebook (NASDAQ: FB), and Salesforce.com (NYSE: CRM) were down 2.2%, 2.9%, and 3.9%, respectively, after falling as much as 8% earlier in the day.

A world eager for progress on vaccines to guard against the SARS-CoV-2 coronavirus and/or COVID-19 might have to wait a bit longer for a breakthrough. The CEO of Moderna (NASDAQ: MRNA), the developer of what many experts consider the leading vaccine candidate, said Friday that h

Today was better than yesterday for the S&P 500 (SNPINDEX: ^GSPC) index, which finished better than it looked for most of the trading day. The index closed down 28 points, or 0.81%, but was down more than 2% for most of morning trading. A late-day rally actually had the ind